Business Wire

TOM FORD Unveils Black Orchid Reserve Campaign Starring Tilda Swinton

Share

The quest for exceptional rarity. Introducing Tilda Swinton for the new TOM FORD Black Orchid Reserve campaign.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828507187/en/

“It is a profound honour for me to play a part in the history of TOM FORD’s legendary Black Orchid. Transformation, the blurring of boundaries and the celebration of magical properties have always drawn me close; Black Orchid Reserve is precisely such an enchantment.” — Tilda Swinton

A celebrated actor and artist, Swinton is a singular presence known for her fearless artistry and transformative performances. An Academy Award, BAFTA and Golden Lion for Lifetime Achievement winner, Swinton defies conventions with elegance, intellect and a visionary approach to cinema. Her work transcends definition, shaping the culture through work in film, art and performance.

TOM FORD creative director Haider Ackermann designed the campaign as a cinematic portrait of rarity in its most heightened form. Lensed by Inez and Vinoodh, the campaign images and video — launching on September 1 — show Swinton in fluid motion. A magnetic force of nature. It is a portrait of a woman who awakens the world around her through gaze and gesture, stillness and strength. She is as rare as the Black Orchid – a flower born of the quest for perfection.

Black Orchid, TOM FORD’s first fragrance, was a revelation when it debuted in 2006. Now, TOM FORD debuts Black Orchid Reserve. The fragrance introduces the Ghost Orchid — a phantom-like flower that is revered as one of the most elusive in the world — with its scent captured by headspace technology the moment the Ghost Orchid blooms. This precious note is a decadent white floral, providing a brilliant contrast to Black Orchid’s rich, dark accords and spice, ushering in a new chapter in the world of TOM FORD’s Black Orchid.

ABOUT TOM FORD

TOM FORD IS A GLOBAL LUXURY HOUSE OFFERING EXCEPTIONAL WOMEN’S AND MEN’S FASHION, ACCESSORIES, EYEWEAR AND BEAUTY.

FOUNDED IN 2005 BY TOM FORD, THE HOUSE IS KNOWN FOR SHARP TAILORING AND SEDUCTIVE ELEGANCE. IT HAS A PRESENCE IN MORE THAN 100 COUNTRIES AND TERRITORIES. THE ESTÉE LAUDER COMPANIES BECAME THE SOLE OWNER OF THE TOM FORD BRAND IN 2023, ESTABLISHING LONG-TERM LICENSES WITH THE ERMENEGILDO ZEGNA GROUP FOR FASHION AND ACCESSORIES, AND MARCOLIN FOR EYEWEAR. HAIDER ACKERMANN WAS APPOINTED CREATIVE DIRECTOR IN 2024.

ABOUT THE ESTÉE LAUDER COMPANIES

The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.

ELC-B

View source version on businesswire.com: https://www.businesswire.com/news/home/20250828507187/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)29.8.2025 12:00:00 CEST | Press release

Study met its primary endpoint of overall response rate (ORR), demonstrating clinically meaningful responses in rare B-cell lymphoma with high unmet needBeOne to submit data to global regulatory authorities for their review and potential approval BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) of sonrotoclax, a next-generation and potentially best-in-class investigational BCL2 inhibitor, in adult patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase inhibitor (BTKi) and anti-CD20 therapy. BeOne plans to present the full data at an upcoming medical meeting. “For people with relapsed or refractory mantle cell lymphoma, the disease is aggressive, the treatment landscape fragmented, and the outcomes unacceptably poor. These topline results for sonrotoclax underscore its potential to deliver meaningful and

Oulu2026 – European Capital of Culture: Oulu to Unveil Full European Capital of Culture 2026 Programme – Live Stream on 4 September 202529.8.2025 10:46:00 CEST | Press release

In just four months, Oulu, with its 39 partner municipalities in Northern Finland, will step into the spotlight as European Capital of Culture 2026. The full programme will be officially launched on Thursday 4 September 2025 in Oulu, streamed live across Europe. Hundreds of partners are creating a year in which Northern Finland becomes a new hub of culture. The programme will offer something for everyone: large-scale exhibitions, festivals across all genres, world premieres, performing arts, village celebrations, permanent artworks, sports, and community events across a vast region of 40 municipalities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250829591577/en/ Oulu, with its 39 partner municipalities in Northern Finland, will step into the spotlight as European Capital of Culture 2026. The full programme will be officially launched on Thursday 4 September 2025 in Oulu, streamed live across Europe. The Oulu2026 programm

Nippon Sanso Holdings Group Unifies Global Brand Logo Launching the "NIPPON SANSO" Brand Worldwide29.8.2025 08:00:00 CEST | Press release

Nippon Sanso Holdings Corporation (President CEO: Toshihiko Hamada) will unify the brand logo for its industrial gas business globally and implement the change in stages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828253560/en/ Until now, our group has operated industrial gas businesses worldwide using the same symbol mark, while adapting to each region. To further enhance recognition and understanding of our group as a unified entity among a broad range of stakeholders, and to maximize corporate value and achieve sustainable growth, we have decided to unify the brand for our industrial gas businesses as "NIPPON SANSO" and standardize the brand logo globally. Moving forward, we will continue striving to be a trusted company for all stakeholders as a globally recognized brand. *Please note that Thermos Group, which operates the consumer household goods business within our group, will not change its brand logo. *The log

Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma28.8.2025 22:15:00 CEST | Press release

Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in achieving a significant regulatory milestone: the approval of Anlotinib Hydrochloride Capsules for a new indication as a first-line treatment for unresectable locally advanced or metastatic soft tissue sarcoma (STS) in combination with chemotherapy. This approval marks the ninth indication for Anlotinib in China and represents the world’s first official approval of an Anlotinib-chemotherapy combination for first-line treatment of advanced or metastatic STS. Previously recommended as a second-line monotherapy by the Chinese Society of Clinical Oncology (CSCO) guidelines, Anlotinib was the only Grade I targeted therapy for STS. This new indication represents a significant advancement for patients who have not previously received systemic treatment, expanding access to more effective and targeted first-line the

BEYOND Developments Reveals the Middle East’s First Forest District by the Sea, Featuring Talea as its First Residential Tower28.8.2025 22:03:00 CEST | Press release

A visionary fusion of architecture and ecology redefining sustainable coastal living in Dubai Maritime City As part of its ongoing commitment to shaping future-focused communities, BEYOND Developments has announced the launch of the Middle East’s first Forest District by the Sea, and Talea, the first in a series of residential towers that will bring this vision to life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828822584/en/ Talea by Beyond, a rare fusion of ocean, forest, and skyline views, where nature and design live in perfect harmony (Photo: AETOSWire) Set in Dubai Maritime City, this pioneering destination is a coastal haven centered on nature, wellness, and sustainability. By championing this nature-first approach, BEYOND Developments supports Dubai’s transformation into a global leader in sustainable, resilient urban living, aligned with the Dubai 2040 Master Plan, Net Zero 2050, and D33 Agenda. According to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye